Medical News

RSS

Patni Computer to provide design and development services to Cardiac Science Corporation

Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced a three-year agreement with Patni Computer Systems under which Patni will establish a dedicated design center in India and will expand Cardiac Science's existing in-house design and development capability.

14 Sep 2009

APDA/NPF Parkinson's conference educates the young onset PD community

The American Parkinson Disease Association (APDA) National Young Onset Center and the National Parkinson Foundation (NPF) Young Onset Parkinson Network are co-sponsoring a series of conferences for those living with young-onset Parkinson's disease and their caregivers. The first conference will be held in Dallas, Texas on October 23-24.

14 Sep 2009

GTx to continue its toremifene Phase III high grade PIN clinical trial for prevention of prostate cancer

GTx, Inc. (Nasdaq: GTXI), today announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN), a precancerous lesion of the prostate.

14 Sep 2009

Revolutions Medical appoints Cirrus Financial Communications for NASDAQ listing

Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it has engaged Cirrus Financial Communications, LLC ("Cirrus") to provide comprehensive financial marketing and investor relations services.

14 Sep 2009

Metric Applications Packages from ClearPoint Metrics

ClearPoint Metrics today announced a major expansion to its product offering with the delivery of four new Compliance oriented Metrics Application Packages (MAPS) and the integration of the ClearPoint Security Performance Manager (TM) and its compliance offering into a single solution - The ClearPoint Unified Security Performance and Compliance Manager.

14 Sep 2009

WillWalk to raise funds for human stem cell trials for people with SCI

WillWalk, an Austin based non-profit organization has committed itself to be at the forefront of ending Paralysis. WillWalk will raise $3 million to help fund the first non-controversial human stem cell trials for people with Spinal Cord Injury (SCI).

14 Sep 2009

Meeting with Obama on health insurance reforms discussed

Speaker Nancy Pelosi and Senate Majority Leader Harry Reid held a brief press availability following their meeting with President Obama at the White House this afternoon. Below is a transcript of their remarks followed by question and answer session.

14 Sep 2009

POS website for one-stop paper shopping experience

POSPaper.com, the Internet’s premier source for point-of-sale supplies, paper products, and accessories, has expanded its website to include a “Restaurant Supplies” section as well as one-stop paper shopping for restaurants, retailers, banks, casinos, resorts, grocers, and more.

14 Sep 2009

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

Salix Pharmaceuticals, Ltd. today announced the successful outcome of two Phase 3, randomized, double-blind, placebo-controlled, multicenter trials, TARGET 1 and TARGET 2, designed to evaluate the efficacy and safety of rifaximin 550 mg TID in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).

14 Sep 2009

IAEA's mission removing radioactive sources from Lebanon completed

An IAEA mission to get powerful radioactive sources out of Lebanon was completed 30 August 2009, after a plane carrying the high-activity cargo safely touched down in Russia, where the sources are now securely and safely stored.

14 Sep 2009

Schizophrenia: A major public health problem

Schizophrenia is a major public health problem. Affecting almost 1% of the world's population, it takes an enormous economic and social toll in addition to the distress, dysfunction, disability and mortality for those afflicted with this disease. Elements of the disease are present from birth, other aspects emerge during developmental years, and the illness becomes fully expressed in early adulthood with long-lasting implications for most patients.

14 Sep 2009

Phase IIa clinical data of EHT 0202 released

Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit’s lead candidate for the treatment of Alzheimer’s disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer’s disease patients.

14 Sep 2009

Phase III STARTMRK clinical study on ISENTRESS in comparison to efavirenz

ISENTRESS , an integrase inhibitor from Merck & Co., Inc., was studied in comparison to efavirenz in maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 cell counts in previously untreated (treatment-naïve) HIV-1-infected patients through 96 weeks in a Phase III study called STARTMRK.

14 Sep 2009

Sleep deprivation is a major factor for clinical errors

A study of clinical errors made by resident physicians in a teaching hospital reveals that the more tired they are the more mistakes they make. The study published in the International Journal of Behavioural and Healthcare Research puts figures to this seemingly obvious conclusion and shows that fewer errors are made if clinical practices are standardised.

14 Sep 2009

Eat healthy foods to prevent flu

As flu season grips the nation with heightened awareness of hand washing and cough covering, healthy eating is a potent prevention method getting left out in the cold.

14 Sep 2009

U.S. Department of Justice awards grant to Project Lifesaver International

Project Lifesaver International, a non-profit organization that helps rescue citizens who are prone to wander due to Alzheimer's disease, autism, and other cognitive disorders, received notification of federal assistance yesterday.

14 Sep 2009

National Conference on Latinos and AIDS

To educate healthcare professionals on how to improve the Latino community's access to HIV/AIDS treatment and care, Minority Health Care Communications (MHCC) will hold the National Conference on Latinos and AIDS, September 14-15th, 2009, at the New York Academy of Medicine in New York.

14 Sep 2009

Given Imaging'c PillCam COLON 2 video capsule and system receives the CE mark for sale in Europe

Given Imaging Ltd. (NASDAQ: GIVN) today announced encouraging results from a trial that validated new features of the company's second-generation PillCam® Colon video capsule and system. The Company also announced that it has obtained the CE mark for the sale of PillCam COLON 2 in Europe.

14 Sep 2009

Clinical data on CXA-101 to be presented at ICAAC

Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.

14 Sep 2009

Innovative stroke treatment device to minimize brain damage

Driven by the emergency-room maxim, "Time is brain," NeuroInterventions, Inc. is prototyping an innovative stroke treatment device designed to speed up the restoration of blood flow and thus minimize brain damage.

14 Sep 2009